BGIG - ETF AI Analysis
Top Page
Bahl & Gaynor Income Growth ETF (BGIG)
BGIG, the Bahl & Gaynor Income Growth ETF, is supported by strong core holdings like Microsoft and TSMC, which benefit from leading positions in cloud, AI, and advanced semiconductor technologies and provide a solid foundation for long-term growth. Other major positions such as Broadcom and Johnson & Johnson further strengthen the fund through solid financial performance and strategic initiatives, while names like AbbVie and Williams Co introduce some risk due to leverage, cash flow, and valuation concerns. The main risk factor is the fund’s meaningful exposure to richly valued, AI-focused and income-oriented companies, which could be vulnerable if growth expectations or cash flow trends weaken.
BGIG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.24B
- Region
- North America
- Expense Ratio
- 0.45%
- Beta
- 0.58
- Issuer
- Bahl & Gaynor
- Inception Date
- Sep 14, 2023
- Dividend Yield
- 1.68%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
BGIG Summary
The Bahl & Gaynor Income Growth ETF (BGIG) is an actively managed fund that focuses on large U.S. companies that pay dividends and have room to grow over time. It doesn’t track a specific index, but instead builds a broad mix across sectors like technology, health care, and financials. Well-known holdings include Microsoft and Johnson & Johnson. Someone might invest in BGIG to seek a mix of regular income from dividends and long-term growth from strong, established businesses. A key risk is that it is heavily invested in U.S. large-cap stocks, so its value can rise and fall with the overall stock market.
How much will it cost me?
BGIG has an expense ratio of 0.45%, which means you’ll pay about $4.50 per year for every $1,000 invested. This cost is higher than the average low-cost index ETF because BGIG is actively managed, with professionals selecting and adjusting the fund’s holdings.
What would affect this ETF?
BGIG could benefit if large U.S. companies in technology, health care, and financials keep growing profits and raising dividends, especially as its top holdings like Microsoft, UnitedHealth, and major banks gain from innovation, strong demand, and a stable economy. On the downside, higher interest rates, stricter regulations on big tech, banks, or drug makers, or an economic slowdown that hurts large-cap U.S. stocks and energy companies could weigh on both the income and growth this ETF aims to deliver.
BGIG Top 10 Holdings
BGIG leans heavily into U.S. large caps, with a clear tilt toward tech and health care. Microsoft and TSMC are the main engines here, with both stocks rising on the back of strong demand for cloud and AI chips. Broadcom, another semiconductor play, has been more mixed lately, softening the tech tailwind. On the defensive side, UnitedHealth and Johnson & Johnson have been steadier, helping balance out volatility, while Chevron adds an energy kicker that’s been supportive over the past few months. Overall, the fund rides an income-focused, blue-chip growth story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MSFT | Microsoft | 5.24% | $117.66M | $3.95T | 0.76% | 79Outperform |
 UNH | UnitedHealth | 4.73% | $106.19M | $376.33B | 15.99% | 72Outperform |
 TSM | TSMC | 4.61% | $103.37M | $1.92T | 43.95% | 81Outperform |
 ABBV | AbbVie | 4.46% | $100.01M | $510.84B | 25.14% | 66Neutral |
 AVGO | Broadcom | 4.24% | $95.17M | $1.60T | -6.57% | 76Outperform |
 CVX | Chevron | 4.10% | $92.09M | $445.95B | 48.96% | 71Outperform |
 JNJ | Johnson & Johnson | 3.98% | $89.31M | $621.22B | 37.07% | 78Outperform |
 PNC | PNC Financial | 3.63% | $81.38M | $88.92B | 23.36% | 71Outperform |
 LLY | Eli Lilly & Co | 3.10% | $69.47M | $1.21T | 55.10% | 72Outperform |
 JPM | JPMorgan Chase | 2.93% | $65.77M | $891.18B | 12.58% | 72Outperform |
BGIG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BGIG, the sentiment is Positive. The current price of 36.74 is above the 20-day moving average (MA) of 35.95, above the 50-day MA of 36.26, and above the 200-day MA of 34.88, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 68.62 is Neutral, neither overbought nor oversold. The STOCH value of 96.05 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BGIG.
BGIG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| BGIG | $36.74 | $40.00(8.87% Upside) | $2.24B | 0.45% | 73Outperform |
 FELC | $42.98 | $53.94(25.49% Upside) | $8.80B | 0.18% | 74Outperform |
 TCAF | $43.04 | $54.56(26.76% Upside) | $8.16B | 0.31% | 69Neutral |
 DIVO | $47.57 | $54.08(13.68% Upside) | $8.09B | 0.56% | 64Neutral |
 GPIQ | $55.21 | $73.51(33.14% Upside) | $6.42B | 0.29% | 72Outperform |
 GPIX | $55.43 | $67.99(22.65% Upside) | $6.38B | 0.29% | 71Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BGIG | Bahl & Gaynor Income Growth ETF | 36.74 | 4.88 | 15.32% | |
| FELC | Fidelity Enhanced Large Cap Core ETF | 42.98 | 5.13 | 13.54% | |
| TCAF | T. Rowe Price Capital Appreciation Equity ETF | 43.04 | 4.13 | 10.63% | |
| DIVO | Amplify CWP Enhanced Dividend Income ETF | 47.57 | 4.97 | 11.67% | |
| GPIQ | Goldman Sachs Nasdaq 100 Core Premium Income ETF | 55.21 | 6.55 | 13.45% | |
| GPIX | Goldman Sachs S&P 500 Core Premium Income ETF | 55.43 | 6.54 | 13.38% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.